BioCentury | Aug 8, 2016
Clinical News

CordIn: Phase I/II started

...Cell began an open-label, international Phase I/II trial to evaluate a single graft transplantation of CordIn...
...Phase I/II trial are expected later this year. Gamida Cell Ltd. , Jerusalem, Israel Product: CordIn...
BioCentury | Jun 20, 2011
Company News

e-Therapeutics management update

e-Therapeutics Ltd. (LSE:ETX), Newcastle, U.K. Business: Infectious, Cancer Hired: Daniel Elger as CFO and a director, formerly VP of marketing and communications at Antisoma plc Departed: J.M. Cordiner as finance director WIR Staff cancer Infectious...
Items per page:
1 - 2 of 2